Fig. 1

Evidence collated during the process of NOACs inclusion into the 21st WHO Model List of Essential Medicines: this table shows data from RCTs and reporting real world data (RWD) about the efficacy of NOACs versus warfarin in reducing stroke in non-valvular AF patients. NOACs were associated with either similar or superior outcomes at preventing stroke event. DOI: http://doi.org/10.5334/gh.608